Metraipolis › archive › dc_0f2fe60310ae
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study — Europe PMC PMID:41780565
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41780565
- DOI
- 10.1093/eurheartj/ehaf1085
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T23:30:45.094Z
- SHA-256 of the archived text
0cd2c5ad15c8ec5bb6ae7ef452564924473c69254217b919178a284829157987- Stable URL of this page
https://metraipolis.com/documento/dc_0f2fe60310ae
How to cite
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study — Europe PMC PMID:41780565 — Europe PMC (en), https://europepmc.org/article/MED/41780565 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0f2fe60310ae (Metraipolis archive dc_0f2fe60310ae, sha256 0cd2c5ad15c8ec5bb6ae7ef452564924473c69254217b919178a284829157987)
BibTeX
@misc{dc0f2fe60310ae,
title = {Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study — Europe PMC PMID:41780565},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41780565},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0f2fe60310ae; sha256 0cd2c5ad15c8ec5bb6ae7ef452564924473c69254217b919178a284829157987},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41780565. Agents can read the archived copy with the MCP tool read_document.